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Late-stage C–H amination of abietane
diterpenoids†
María Ivana Lapuh,a,b Alejandro Dana,b Pablo H. Di Chenna, b Benjamin Darses,a
Fernando J. Durán*b and Philippe Dauban *a
This study aims at highlighting the synthetic versatility of the rhodium-catalyzed C–H amination reactions
using iodine(III) oxidants for the late-stage functionalization of natural products. Inter- and intramolecular
nitrene insertions have been performed from various abietane diterpenoids, leading to the amination of
the C-3, C-6, C-7, C-11 and C-15 positions. Ca. 20 aminated compounds have been isolated with yields
of up to 86% and high levels of regio-, chemo- and stereoselectivities.
Introduction
Catalytic C–H functionalization has emerged in the last decade
as a unique tool that opens new horizons in chemical syn-
thesis with the aim to generate a greater molecular diversity
and complexity.1 The ability to perform site-selective reactions
through the development of appropriate conditions and well-
designed catalysts provides rapid access to unprecedented
functionalized molecules. Of particular relevance, in this
context, is the late-stage C–H functionalization of natural pro-
ducts and bioactive compounds. Such a simple transformation
allows for the modification of sophisticated molecules in a
single step thereby affording new products that would be
difficult to access by application of classical organic reactions
relying on the manipulation of existing functionalities.2
The late-stage C–H functionalization strategy can be useful
when the introduction of a nitrogen functionality is con-
sidered in the course of a medicinal chemistry program. A
nitrogen group can indeed deeply impact either the activity or
the bioavailability of a pharmaceutical, a unique feature that
makes this atom present in more than 80% of the drugs
approved by the U.S. FDA.3 The C–H amination reaction, there-
fore, offers unique opportunities to modify a bioactive natural
product and fine tune its profile; particularly, it could afford
new compounds that nature cannot produce as no known
enzyme is programmed to convert a C–H into a C–N bond.4
Significant achievements in C(sp3)–H amination reactions
have recently been reported by application of metal-catalyzed
nitrene transfers.5 Worth mentioning are the efficient proto-
cols that have been uncovered by combining dirhodium(II) cat-
alysis and iodine(III) oxidants.6 Selective inter- and intra-
molecular processes have been reported under these con-
ditions allowing the introduction of a nitrogen at specific
sites. Thus, intermolecular reactions preferentially occur at
secondary benzylic and allylic positions or non-activated ter-
tiary centres, whereas intramolecular reactions lead to the
selective amination of C–H bonds β- or γ- to the nitrene-donor
functionality. Such a set of conditions, therefore, is appropri-
ate to derivatize any natural product to a large number of
nitrogen-containing scaffolds.
In this context, abietane diterpenoids of type A (Fig. 1) have
appeared to us as a textbook case to apply dirhodium(II)-cata-
lyzed C–H amination reactions for the formation of a library of
diversely substituted amino compounds. These naturally
occurring tricyclic diterpenoids isolated from terrestrial plant
sources have been the purpose of several synthetic studies that
have led to the formation of a wide range of compounds dis-
playing either antimicrobial, antifungal, antiprotozoal, or anti-
cancer activities, to name but a few.7
With the aim to increase the variety of accessible analogues,
recent studies have demonstrated that catalytic C(sp3)–H
functionalization reactions can be successfully applied to
dehydroabietic acid analogues (Fig. 1a). Amide-directed
C(sp3)–H activation, thus, allows the introduction of alkyl,8a
amino,8b boryl,8c chloro,8d or aryl8e substituents selectively at
the C-19 position. Two isolated examples of amination at the
C-7 benzylic centre have also been reported following the
application of intermolecular C(sp3)–H amination.9 In this
communication, we, therefore, wish to present the results of
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our investigations on the application of catalytic nitrene trans-
fers to various abietane derivatives that has led to the isolation
of diversely substituted amino derivatives (Fig. 1b).
Results and discussion
Catalytic intermolecular C(sp3)–H amination reactions
We first investigated the application of catalytic intermolecular
nitrene C(sp3)–H insertions into various abietane derivatives
(Scheme 1). All the reactions were developed under stoichio-
metric conditions with respect to the starting material.
Substrates 1–5 are easily accessible from dehydroabietic acid,
with compound 2 being prepared following a sequence of acy-
lation–Baeyer–Villiger oxidation–saponification–methylation
adapted from a synthesis of taiwaniaquinone F (see the
ESI†).10 Compounds 6–7 are directly obtained from podocarpic
acid. We, then, performed the C(sp3)–H amination reaction
using the conditions previously reported by Du Bois.11
When applied to dehydroabietic acid derivatives 1–5, the
reaction selectively affords products resulting from the
functionalization of the secondary benzylic C-7 centre. Very
good yields in the 46–86% range are obtained with the
α-isomer being preferentially formed, with α : β ratios around
4.5 : 1. Interestingly, starting from podocarpic acid derivatives
6 and 7, the α-isomers 13 and 14 are exclusively isolated in
75% and 76% yields respectively. We propose to rationalize
this excellent selectivity by the involvement of stereoelectronic
factors. According to the dihedral angle with the adjacent aro-
matic ring, hyperconjugation could increase the reactivity of
the α-C(sp3)–H bond, favouring the insertion from the α-face.
However, the lower selectivities observed with dehydroabietic
acid substrates 1–5 might result from the increased steric hin-
drance provided by the C-18 substitution.
The same reaction conditions were applied to abietic acid
derivatives 15 and 16 (Scheme 2). In both cases, we have iso-
lated the same products as those obtained from the corres-
ponding dehydroabietic acid analogues 1 and 4, with higher
selectivities in favour of the α-isomers but lower yields. These
results are reminiscent of previous observations made in the
total synthesis of hispidospermidin by Overman.12
Accordingly, a possible mechanism for the formation of 8 and
11 from, respectively, 15 and 16 would involve an initial formal
ene reaction followed by an aromatization of the resulting 1,3-
cyclohexadiene intermediate.
Surprisingly, the application of our reported conditions for
catalytic stereoselective C(sp3)–H amination13 led to totally
different results (Scheme 3). While they proved unsuccessful
from aromatic abietanes 1–6, they afforded a single
product arising from a C(sp3)–H amination reaction at the
allylic centre C-15 in the case of abietane substrates 15 and 16.
Such a switch in regioselectivity could be explained by steric
Scheme 1 Rhodium(II)-catalyzed intermolecular C(sp3)–H amination
reaction of dehydroabietic acid and podocarpic acid derivatives.
Reaction conditions: (a) Rh2(esp)2 2 mol%, TcesNH2 1 equiv., PhI(OPiv)2
2 equiv., benzene, rt. Tces = 2,2,2-trichloroethoxysulfonyl.
Scheme 2 Rhodium(II)-catalyzed intermolecular C(sp3)–H amination
reaction of abietic acid derivatives. Reaction conditions: (a) Rh2(esp)2
2 mol%, TcesNH2 1 equiv., PhI(OPiv)2 2 equiv., benzene, rt.
Fig. 1 Background for the study.
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factors as the C-15 position is the more accessible reacting site
for the sterically demanding sulfonimidamide-derived reagent.
Matched and mismatched effects were also observed as higher
yields are recorded by using the (R,R)-pair of reagent and
catalyst.
Application of the catalytic intermolecular C(sp3)–H amination
to the synthesis of the fluorinated aminoabietane derivative 21
Increasing attention has been paid to the synthesis of fluori-
nated compounds as fluorine might strongly influence either
the lipophilicity, the metabolic stability, or the conformation
of a drug.14 For example, the CF2H group is now considered as
a lipophilic H-bond donor acting as a bioisostere of a hydroxyl,
thiol, or amide group.14a The growing impact of fluorine is
demonstrated by its presence in nearly 30% of pharmaceuti-
cals and agrochemicals, while it was absent in medicinal
chemistry until 1957. This, combined with the aforementioned
ubiquity of nitrogen, led us to plan the synthesis of the modi-
fied abietane diterpenoid 21 incorporating both nitrogen- and
fluorine-containing functional groups (Scheme 4).
Starting from iodoarene 7, introduction of the ethyl difluor-
oacetate moiety proceeds efficiently via copper(0)-mediated
coupling in DMSO.15 After the selective saponification of the
ethyl ester group, carboxylic acid 19 was isolated in 81% yield.
A three-step sequence involving a Barton decarboxylation reac-
tion,16 then, affords the difluoromethyl derivative 20.
Application of the rhodium(II)-catalyzed intermolecular C(sp3)–
H amination, finally, delivers the targeted molecule 21 with an
excellent yield of 83%.17 This transformation, to the best of
our knowledge, highlights for the first time the compatibility
of the C(sp3)–H amination reaction with the presence of a
CF2H group. This is a significant result in our case because
application of classical conditions for the introduction of the
CF2H group all proved unsuccessful in the presence of an
amino function.17
Catalytic intramolecular C(sp3)–H amination reactions
We, then, turned our attention to the use of intramolecular
nitrene C(sp3)–H insertions to increase the number of posi-
tions likely to be functionalized. The design of tethered
reagents has indeed been shown to allow the modification of
specific sites according to the nature of the nitrene donor.18
To this end, sulfamates 22, 24, 26, 28, and 3019 as well as car-
bamate 32 were easily prepared from abietic, dehydroabietic
and podocarpic acids (Scheme 5).
Starting from sulfamate 22, the reaction delivers a single
product resulting from the intramolecular C(sp3)–H amination
at the C-3 position. Compound 23 is isolated with a very good
yield of 71% as a single stereoisomer arising from the selective
functionalization of the axial C-3(sp3)–H bond.20 The same
selectivity was observed from the unsaturated analogue 24 that
leads to the tetracyclic derivative 25 though with a lower yield
of 42%. The latter could be explained by the formation of aziri-
dine 34 arising from a dimerization process as a result of the
intermolecular alkene aziridination of the cyclic sulfamate 25
(Fig. 2). We propose that 1,3-diaxial interaction induced by the
axial C-19 methyl substituent may prevent the reaction from
proceeding at the equatorial C-3–H bond thereby explaining
the selectivity observed for the amination of 22 and 24. The
podocarpic acid-derived sulfamate 26, on the other hand,
allows for the isolation of the analogous C-3 aminated com-
pound 27 in 41% yield that arises from the amination from
the β-face. Interestingly, products 23, 25, 27, and 34 are rare
examples of abietane diterpenoid analogues functionalized at
the A-ring.7
When the same reaction conditions were applied to the
abietic acid derivative 28, a switch of regioselectivity was unex-
pectedly observed. Thus, the intramolecular C(sp3)–H insertion
takes place at the C-6 position delivering product 29 in 29%
yield as a single isomer.21 The latter is a rare example of a
7-membered ring obtained by intramolecular C(sp3)–H amin-
Scheme 3 Catalytic intermolecular C(sp3)–H amination with sulfonimi-
damides. Reaction conditions: (a) Rh2(S- or R-nta)4 3 mol%, S*NH2 1.2
equiv., PhI(OPiv)2 1.4 equiv., TCE : MeOH 3 : 1, −35 °C. S*: (S)- or (R)-(N-
(p-toluenesulfonyl)-p-toluenesulfonimidoyl. TCE: 1,1,2,2-
tetrachloroethane.
Scheme 4 Synthesis of the nitrogen- and fluorine-containing abietane
derivative 21. Reaction conditions: (a) BrCF2CO2Et, Cu, DMSO, 60 °C,
15 h; (b) LiOH 1.25 M, THF, MeCN, rt, 2 h, 19 81% (2 steps); (c) oxalyl
chloride, 10 mol% DMF, DCM, rt; (d) 2-mercaptopyridine N-oxide
sodium salt, DMAP, n-Bu3SnH, toluene, reflux, 2 h, 20 31% (3 steps); (e)
Rh2(esp)2 5 mol%, TcesNH2 1 equiv., PhI(OPiv)2 2 equiv., benzene, rt, 21
83%.
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ation,22 the structure of which was corroborated by compari-
son between the NMR spectra of substrate 28 and the resulting
product 29 (see the chemical shifts of H-7, C-3 and C-6 in the
ESI†). The formation of the 7-membered cyclic sulfamate
could be rationalized by the increased reactivity of the allylic
C–H bond.
Additional intramolecular reactions have also been
designed by capitalizing on the presence of the phenol ring in
dehydroabietic acid derivatives. Classical reaction conditions
applied to sulfamate 30, therefore, allows for the amination of
the tertiary benzylic position in 76% yield. More significantly,
the use of carbamate 32 offers the opportunity to functionalize
the aromatic C-ring, thereby enhancing the potential of this
chemistry for late-stage amination. Following the recent proto-
col reported by Singh,23 the rhodium-catalyzed electrophilic
aromatic substitution, thus, proceeds at the ortho C(sp2)–H
bond thereby leading to the functionalization of the C-11
site.24
Conclusions
In conclusion, we have demonstrated that the rhodium(II)-cata-
lyzed C–H amination reaction with iodine(III) oxidants is a
useful tool for the late-stage functionalization of natural com-
pounds with the aim to produce new analogues. By application
of inter- and intramolecular processes and/or screening
different nitrene precursors and rhodium(II) complexes, we
have been able to selectively introduce an amino functional
group either at C-3, C-6, C-7, C-11 or C-15 positions of various
abietane diterpenoids. Ca. 20 derivatives were, thus, isolated
with yields ranging from 12% to 86%, but also with high levels
of chemo-, regio- and stereoselectivities. Worth mentioning is
the compatibility of the reaction conditions with the presence
of a CF2H group.
The difference in the regioselectivity observed between the
various abietane derivatives highlights that the course of the
nitrene insertion is controlled by the subtle balance of steric
and stereoelectronic factors. Such a study, therefore, is likely to
provide useful information with the aim to perform C(sp3)–H
functionalization reactions with high levels of predictability.
Work in that direction is in progress in our group through the
application of catalytic nitrene transfers to other classes of
natural products available at the ICSN.
Experimental
Melting points were measured in a Fisher-Johns melting point
apparatus and are uncorrected. Infrared spectra were recorded
on a PerkinElmer Spectrum BX FT-IR spectrometer and a
Scientific Nicolet iS50 FT-IR. Specific rotation was measured
on a PerkinElmer 343 polarimeter. Proton (1H) and carbon
(13C) NMR spectra were recorded on Bruker spectrometers:
Avance 300 MHz (QNP-C13, P31, or Dual C13 probe), Fourier
300 MHz (Easy probe, 1H and 13C standard 5 mm probe),
Scheme 5 Rhodium(II)-catalyzed intramolecular C(sp3)–H amination.
Reaction conditions: Rh(II) complex 3 or 5 mol%, MgO, PhI(OAc)2 1.3 equiv.
Fig. 2 Aziridine 34 resulting from a dimerization process from 24
according to an intramolecular C(sp3)–H amination followed by the
intermolecular alkene aziridination.
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Avance 500 MHz (BBO-ATM probe or BBI-ATM probe),
Avance II 500 MHz (BBO-ATM probe or BBI-ATM probe) and
Avance Neo 500 (BBO-ATM probe or BBI-ATM probe). Fluorine
(19F) NMR were recorded on a Bruker Avance II spectrometer.
Carbon (13C) spectra were recorded at 126 or 75 MHz, using a
broadband decoupled mode with the multiplicities obtained
using a JMOD or DEPT sequence. NMR experiments were
carried out in deuterated chloroform (CDCl3). Chemical
shifts (δ) are reported in parts per million (ppm) with refer-
ence to tetramethylsilane (TMS) or residual solvent peaks as
internal standards. The following abbreviations are used for
the proton spectra multiplicities: s: singlet, d: doublet,
t: triplet, q: quartet, sept: septet, m: multiplet, dd: doublet of
doublets, dt: doublet of triplets, td: triplet of doublets, ddd:
doublet of doublet of doublets, tdd: triplet of doublet of
doublets, qt: quartet of triplets, tt: triplet of triplets, and br:
broad. Coupling constants ( J) are reported in hertz (Hz). Mass
spectra were obtained with an LCT (Micromass) or with a
Bruker MicroTOF-Q II instrument using electrospray ionization
and from a time of flight analyzer for the high resolution mass
spectra (HRMS). Thin layer chromatography was performed on
silica gel 60 F254 on aluminium plates (Merck) and visualized
under a UVP Mineralight UVLS-29 lamp (254 nm) and by stain-
ing with acidic solutions of vanillin in ethanol, p-anisaldehyde
in ethanol, potassium permanganate or cerium molybdate.
Flash chromatography was conducted on Merck silica gel 60
(40–63 µm) at medium pressure (300 mbar) or on puriFlash
Spot II (Interchim) unless otherwise stated. All reagents were
obtained from commercial suppliers unless otherwise stated.
The rhodium catalysts Rh2(NHCOCF3)4 and Rh2(S- or R-nta)4
were prepared according to the literature procedures from
rhodium(II) acetate which was purchased from the Alfa Aesar
company.13,25 Sulfonimidamides were prepared following the
previously published protocols.13,26 Where necessary, organic
solvents were routinely dried and/or distilled prior to use and
stored over molecular sieves under argon. Organic extracts were
dried over sodium sulfate (Na2SO4).
General procedure 1: Intermolecular C(sp3)–H amination reac-
tion with Rh2(esp)2 and TcesNH2 (compounds 8–14 and 21)
A flask containing TcesNH2 (137 mg, 0.600 mmol) and
benzene (0.60 ml) was charged with Rh2(esp)2 (9.1 mg,
12 µmol) and substrate (0.600 mmol). To this bright green
mixture was added a 0.83 M benzene solution of PhI(OPiv)2
(1.40 ml, 1.20 mmol) via a syringe pump over 3 h. Following
the transfer of the oxidant, the solution was stirred at 23 °C for
2–4 h. DCM (5 ml) and 2 ml of a saturated aqueous solution of
thiourea were then added, and the orange biphasic mixture
was stirred vigorously for 30 min. The contents were trans-
ferred to a separatory funnel, and the organic phase was col-
lected. The aqueous layer was extracted with DCM (2 × 10 ml).
The combined organic extracts were washed with a 0.1 M pH 7
Na2HPO4/NaH2PO4 buffer (2 × 10 ml), dried over Na2SO4, fil-
tered, and the filtrate was concentrated under reduced
pressure. Purification of the isolated material by flash chroma-
tography afforded the desired product.
General procedure 2: Intermolecular C(sp3)–H amination with
sulfonimidamides (compounds 17 and 18)
In an oven-dried tube were introduced activated 4 Å mole-
cular sieves (100 mg), Rh2[(S/R)-nta]4 (7.7 mg, 6.0 µmol),
(R/S)-N-(p-toluenesulfonyl)-p-toluenesulfonimidamide (77.9 mg,
0.240 mmol) and the substrate (0.200 mmol). The tube was
capped with a rubber septum and purged with argon.
Anhydrous and degassed 1,1,2,2-tetrachloroethane (0.75 ml)
and methanol (0.25 ml) were added under argon. The tube was
cooled to −78 °C, and PhI(OPiv)2 (115 mg, 0.280 mmol) was
added. The mixture was stirred at −35 °C for 3 days. After
dilution with DCM (3 ml), the molecular sieves were removed
by filtration and the filtrate was evaporated to dryness under
reduced pressure. The oily residue was purified by flash




8 was prepared following general procedure 1 starting from 1
(189 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 90 : 10), compound 8 (206 mg,
63%) was obtained as a white amorphous solid. Integration by
1H NMR provides a ratio of 5 : 1 α : β isomers. The same
compound was prepared as well starting from 15 (190 mg,
0.600 mmol). Purification affords 8 (114 mg, 36%). Integration
by NMR provides a ratio of >20 : 1 α : β isomers.
NMR signals of the major isomer α: 1H NMR (500 MHz,
CDCl3) δ 7.30 (d, J = 1.9 Hz, 1H), 7.20 (d, J = 8.3 Hz, 1H), 7.15
(dd, J = 8.3, 2.0 Hz, 1H), 5.48 (d, J = 8.1 Hz, 1H), 4.80–4.75
(m, 1H), 4.75 (d, J = 10.8 Hz, 1H), 4.69 (d, J = 10.8 Hz, 1H), 3.73
(s, 3H), 2.87 (sept, J = 6.9 Hz, 1H), 2.31 (dd, J = 12.6, 1.2 Hz,
1H), 2.34–2.26 (m, 1H), 2.12 (ddd, J = 14.1, 12.7, 4.9 Hz, 1H),
1.85–1.69 (m, 4H), 1.65 (td, J = 14.2, 13.5, 4.6 Hz, 1H), 1.43 (td,
J = 13.0, 3.9 Hz, 1H), 1.28 (s, 3H), 1.23 (d, J = 6.9 Hz, 6H), 1.20
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 178.9, 147.3, 147.1,
132.8, 128.5, 127.1, 124.9, 93.9, 78.1, 54.2, 52.6, 47.1, 40.7,
38.0, 37.4, 36.9, 33.7, 29.2, 24.3, 24.1, 24.0, 18.6, 16.5. NMR
signals of the minor isomer β that can be distinguished:
1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 1.9 Hz, 1H), 7.19 (d,
J = 8.1 Hz, 1H), 7.15 (dd, J = 8.3, 2.0 Hz, 1H), 7.13 (dd, J = 8.3,
1.9 Hz, 1H), 4.92–4.82 (m, 1H), 4.74 (d, J = 10.8 Hz, 1H), 4.71
(d, J = 10.8 Hz, 1H), 3.67 (s, 3H), 1.92–1.83 (m, 2H). 13C NMR
(126 MHz, CDCl3) δ 178.4, 147.9, 147.2, 133.0, 126.5, 126.1,
124.8, 55.7, 52.3, 47.3, 37.3, 36.7, 33.8, 31.5, 25.6, 24.2, 18.5. IR
(ATR, neat): ν = 3271, 2955, 2935, 1725, 1705, 1435, 1362, 1248,
1179, 1127, 1052, 980, 894, 748, 720 cm−1. HRMS ESI (+):





9 was prepared following general procedure 1 starting from 2
(207 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 85 : 15), product 9 (239 mg,
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70%) was obtained as a white amorphous solid. Integration by
1H NMR provides a ratio of 5 : 1 α : β isomers.
NMR signals of the major isomer α: 1H NMR (500 MHz,
CDCl3) δ 7.23 (s, 1H), 6.67 (s, 1H), 5.37 (d, J = 7.8 Hz, 1H), 4.74
(d, J = 10.8 Hz, 1H), 4.76–4.69 (m, 1H), 4.69 (d, J = 10.8 Hz,
1H), 3.81 (s, 3H), 3.73 (s, 3H), 3.22 (sept, J = 6.6 Hz, 1H), 2.33
(dd, J = 12.7, 1.3 Hz, 1H), 2.30–2.23 (m, 1H), 2.09 (ddd, J =
14.2, 12.7, 4.8 Hz, 1H), 1.85–1.71 (m, 4H), 1.67 (td, J = 13.3,
4.3 Hz, 1H), 1.47 (td, J = 13.2, 3.2 Hz, 1H), 1.28 (s, 3H), 1.21
(s, 3H), 1.20 (d, J = 6.9 Hz, 3H), 1.19 (d, J = 6.9 Hz, 3H).
13C NMR (126 MHz, CDCl3) δ 178.8, 157.3, 148.2, 136.2, 128.1,
124.7, 106.0, 93.9, 78.1, 55.5, 53.9, 52.6, 47.2, 40.7, 38.1, 37.7,
36.8, 29.2, 26.8, 24.3, 22.9, 22.6, 18.7, 16.5. NMR signals of the
minor isomer β that can be distinguished: 1H NMR (500 MHz,
CDCl3) δ 7.30 (s, 1H), 6.68 (s, 1H), 4.86–4.79 (m, 1H), 3.67
(s, 3H), 3.28–3.19 (m, 1H), 1.29 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 178.4, 156.9, 148.9, 135.9, 125.8, 124.8, 106.1, 78.3,
55.6, 55.4, 53.8, 52.4, 47.3, 43.9, 37.6, 36.7, 31.6, 27.0, 25.5,
22.8, 22.7, 18.5. IR (ATR, neat): ν = 3260, 2951, 1703, 1502,
1435, 1361, 1249, 1178, 1046, 976, 957, 848, 749, 721 cm−1.





10 was prepared following general procedure 1 starting from 3
(265 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 90 : 10), product 10 (345 mg,
86%) was obtained as a white amorphous solid. Integration by
1H NMR gives a ratio of 5 : 1 α : β isomers.
NMR signals of the major isomer α: 1H NMR (500 MHz,
CDCl3) δ 7.68 (s, 1H), 7.31 (s, 1H), 5.67 (d, J = 8.1 Hz, 1H), 4.73
(d, J = 10.8 Hz, 1H), 4.75–4.70 (m, 1H), 4.68 (d, J = 10.8 Hz,
1H), 3.71 (s, 3H), 3.10 (sept, J = 6.7 Hz, 1H), 2.25 (br d, J =
12.6 Hz, 1H), 2.29–2.19 (m, 1H), 2.10 (ddd, J = 14.1, 12.7,
5.1 Hz, 1H), 1.91–1.65 (m, 4H), 1.60 (td, J = 13.2, 4.7 Hz, 1H),
1.42 (td, J = 13.1, 4.4 Hz, 1H), 1.27 (s, 3H), 1.22 (d, J = 6.7 Hz,
6H), 1.19 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 178.9, 149.1,
148.9, 136.1, 133.6, 128.0, 102.0, 93.8, 78.1, 53.6, 52.6, 46.9,
40.5, 37.9, 37.8, 37.4, 36.8, 29.0, 24.3, 23.2, 23.1, 18.5, 16.4.
NMR signals of the minor isomer β that can be distinguished:
1H NMR (500 MHz, CDCl3) δ 7.66 (s, 1H), 7.38 (s, 1H), 5.09
(d, J = 9.2 Hz, 1H), 4.84–4.75 (m, 1H), 3.67 (s, 3H), 3.11 (sept,
J = 6.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 178.3, 149.9,
148.7, 136.0, 133.9, 125.6, 101.4, 93.6, 78.3, 55.3, 52.4, 47.2,
37.1, 36.6, 31.1, 25.6, 18.3, 16.5. IR (ATR, neat): ν = 3257,
2957, 2869, 1700, 1469, 1434, 1362, 1247, 1179, 977, 849,
752, 721 cm−1. HRMS ESI (−): m/z [M + H]− calcd for
C23H30Cl3INO5S
−: 663.9960; found: 663.9969.
7-(((2,2,2-Trichloroethoxy)sulfonyl)amino)-8,11,13-abietatrien-
18-yl acetate (11)
11 was prepared following general procedure 1 from 4
(197 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 90 : 10), product 11 was
obtained (213 mg, 64%) as a white amorphous solid.
Integration by NMR provides a ratio of 4.6 : 1 α : β isomers.
The same compound was prepared as well starting from 16
(198 mg, 0.600 mmol). Purification affords 11 (71 mg, 21%).
Integration by 1H NMR provides a ratio of >10 : 1 α : β isomers.
NMR signals for the major isomer α: 1H NMR (500 MHz,
CDCl3) δ 7.27 (d, J = 2.0 Hz, 1H), 7.23 (d, J = 8.3 Hz, 1H), 7.17
(dd, J = 8.2, 2.0 Hz, 1H), 5.08 (d, J = 7.1 Hz, 1H), 4.83–4.77 (m,
1H), 4.73 (s, 2H), 3.97 (d, J = 11.3 Hz, 1H), 3.77 (d, J = 11.4 Hz,
1H), 2.87 (sept, J = 6.8 Hz, 1H), 2.33–2.26 (m, 1H), 2.25–2.19
(m, 1H), 2.06 (s, 3H), 1.99 (ddd, J = 14.1, 12.9, 4.7 Hz, 1H), 1.86
(dd, J = 12.9, 1.4 Hz, 1H), 1.88–1.65 (m, 2H), 1.53 (td, J = 13.5,
4.3 Hz, 1H), 1.45–1.32 (m, 2H), 1.23 (d, J = 7.0 Hz, 6H), 1.19 (s,
3H), 0.93 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.3, 147.7,
147.3, 132.2, 128.2, 127.3, 125.1, 93.9, 78.0, 71.4, 54.2, 39.2,
38.2, 37.8, 36.5, 35.2, 33.7, 26.2, 24.8, 24.2, 24.0, 21.1, 18.6,
17.8. NMR signals of the minor isomer β that can be distin-
guished: 1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 2.0 Hz, 1H),
7.21 (d, J = 8.4 Hz, 1H), 7.14 (dd, J = 8.2, 2.1 Hz, 1H), 5.00–4.90
(m, 1H), 4.77 (d, J = 10.9 Hz, 1H), 4.74 (d, J = 10.9 Hz, 1H), 3.90
(d, J = 11.2 Hz, 1H), 3.75 (d, J = 11.2 Hz, 1H), 2.51–2.44 (m,
1H), 2.03 (s, 3H), 0.94 (s, 3H). 13C NMR (126 MHz, CDCl3)
δ 148.1, 147.1, 133.0, 126.5, 126.0, 124.9, 78.3, 72.0, 55.9, 43.2,
38.3, 36.7, 35.3, 33.8, 26.2, 25.9, 18.4, 17.6. IR (ATR, neat):
ν = 2953, 2836, 1716, 1641, 1572, 1492, 1464, 1435, 1375, 1291,
1264, 1252, 1237, 1216, 1189, 1173, 1149, 1136, 1070, 1049,
973, 877, 802, 788, 773, 734, 771 cm−1. HRMS ESI (+): m/z





12 was prepared following general procedure 1 from 5
(180 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 90 : 10), compound 12
was obtained (145 mg, 46%) as a white amorphous solid.
Integration by 1H NMR provides a ratio of 4.4 : 1 α : β isomers.
NMR signals of the major isomer α: 1H NMR (500 MHz,
CDCl3) δ 7.27 (d, J = 2.1 Hz, 1H), 7.19 (d, J = 8.2 Hz, 1H), 7.13
(dd, J = 8.2, 2.0 Hz, 1H), 5.61 (d, J = 8.5 Hz, 1H), 4.75–4.71 (m,
1H), 4.69 (s, 2H), 3.38 (d, J = 9.2 Hz, 1H), 3.36 (s, 3H), 2.86
(sept, J = 6.9 Hz, 1H), 2.81 (d, J = 9.2 Hz, 1H), 2.27–2.20 (m,
1H), 2.12–2.01 (m, 1H), 1.99–1.92 (m, 1H), 1.91 (d, J = 12.6 Hz,
1H), 1.86–1.62 (m, 3H), 1.40–1.27 (m, 2H), 1.23 (d, J = 6.9 Hz,
6H), 1.19 (s, 3H), 0.82 (s, 3H). 13C NMR (75 MHz, CDCl3)
δ 147.7, 146.9, 133.0, 128.4, 126.8, 125.2, 93.9, 80.9, 78.1,
59.3, 54.7, 42.8, 39.1, 38.7, 37.9, 36.8, 35.5, 33.7, 26.0, 24.2
(1C + 1C), 24.0, 18.9, 18.0. NMR signals of the minor isomer β
that can be distinguished: 1H NMR (500 MHz, CDCl3) δ 7.36
(d, J = 2.0 Hz, 1H), 7.10 (dd, J = 8.2, 2.0 Hz, 1H), 4.88–4.80 (m,
1H), 4.76 (d, J = 10.8 Hz, 1H), 3.30 (s, 3H), 3.21 (d, J = 9.2 Hz,
1H, 1H), 2.50–2.42 (m, 1H), 1.55 (td, J = 13.6, 4.3 Hz, 1H), 1.22
(d, J = 7.0 Hz, 6H), 0.86 (s, 3H). 13C NMR (75 MHz, CDCl3)
δ 148.4, 146.8, 133.1, 126.3, 125.8, 125.0, 81.9, 78.3, 59.4, 56.1,
42.8, 38.5, 37.7, 37.3, 35.4, 33.8, 28.7, 25.8, 18.7, 17.9. IR (ATR,
neat): ν = 3322, 2961, 2929, 2865, 1447, 1418, 1363, 1177, 1102,
1088, 1023, 969, 874, 857, 837, 766, 753, 717 cm−1. HRMS ESI
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13 was prepared following general procedure 1 starting from 6
(181 mg, 0.600 mmol). After purification by flash chromato-
graphy (petroleum ether/EtOAc 80 : 20), 13 was obtained
(240 mg, 76%) as a white amorphous solid.
[α]20D = +77.6 (c = 1.00 in CHCl3).
1H NMR (500 MHz, CDCl3)
δ 7.33 (d, J = 8.4 Hz, 1H), 6.80 (d, J = 2.6 Hz, 1H), 6.78 (dd, J =
8.4, 2.6 Hz, 1H), 4.84 (d, J = 6.2 Hz, 1H), 4.83–4.79 (m, 1H),
4.74 (d, J = 10.6 Hz, 1H), 4.72 (d, J = 11.0 Hz, 1H), 3.79 (s, 3H),
3.65 (s, 3H), 2.63–2.57 (m, 1H), 2.38–2.30 (m, 1H), 2.26–2.17
(m, 2H), 1.98 (qt, J = 13.6, 3.5 Hz, 1H), 1.69 (dd, J = 13.0, 1.3
Hz, 1H), 1.70–1.62 (m, 1H), 1.37 (td, J = 13.3, 3.9 Hz, 1H), 1.31
(s, 3H), 1.13 (td, J = 13.6, 4.1 Hz, 1H), 0.98 (s, 3H). 13C NMR
(75 MHz, CDCl3) δ 177.6, 160.0, 150.6, 131.6, 124.7, 112.7,
111.2, 93.8, 78.1, 55.4, 54.2, 51.5, 46.5, 43.7, 39.2, 38.7, 37.6,
28.5, 27.8, 22.2, 19.9. IR (ATR, neat): ν = 3258, 2947, 2878,
2847, 1723, 1701, 1610, 1434, 1359, 1269, 1230, 1177, 1147,
1047, 980, 847, 752, 721 cm−1. HRMS ESI (+): m/z [M + Na]+
calcd for C21H28Cl3NNaO6S
+: 550.0595; found: 550.0597.
Methyl 7α-(((2,2,2-trichloroethoxy)sulfonyl)amino)-13-iodo-
O-methylpodocarpate (14)
14 was prepared following general procedure 1 starting from 7
(257 mg, 0.600 mmol). After purification by flash chroma-
tography (petroleum ether/EtOAc 80 : 20), compound 14 was
obtained (295 mg, 75%) as a white amorphous solid.
[α]20D = +70.3 (c = 1.00 in CHCl3).
1H NMR (500 MHz, CDCl3)
δ 7.82 (s, 1H), 6.68 (s, 1H), 4.88 (d, J = 6.4 Hz, 1H), 4.79–4.75
(m, 1H), 4.75 (d, J = 10.8 Hz, 1H), 4.73 (d, J = 10.8 Hz, 1H), 3.85
(s, 3H), 3.66 (s, 3H), 2.60–2.53 (m, 1H), 2.38–2.31 (m, 1H),
2.26–2.19 (m, 1H), 2.20 (ddd, J = 14.9, 13.1, 4.2 Hz, 1H), 1.99
(qt, J = 13.8, 3.6 Hz, 1H), 1.71–1.65 (m, 1H), 1.66 (dd, J = 12.9,
1.6 Hz, 1H), 1.37 (td, J = 13.3, 4.1 Hz, 1H), 1.31 (s, 3H), 1.13
(td, J = 13.6, 4.2 Hz, 1H), 0.98 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 177.5, 158.6, 151.0, 141.0, 126.8, 107.7, 93.7, 84.3,
78.1, 56.5, 53.6, 51.6, 46.3, 43.7, 39.2, 38.9, 37.5, 28.5, 27.9,
22.1, 19.8. IR (ATR, neat): ν = 3257, 2945, 2881, 2849, 1722,
1701, 1590, 1486, 1442, 1358, 1303, 1281, 1228, 1175, 1147,
1081, 1042, 980, 957, 846, 746, 721 cm−1. HRMS ESI (−): m/z




17a was prepared following general procedure 2 starting from
15 (63.3 mg, 0.200 mmol) and the (S,S) pair of reagents. After
purification by flash chromatography (DCM/EtOAc 95 : 5), com-
pound 17a was obtained (37 mg, 29%) as a yellow amorphous
solid.
[α]20D = +1.9 (c = 0.53 in CHCl3).
1H NMR (300 MHz, CDCl3)
δ 7.82 (d, J = 8.3 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.25 (d, J =
8.8 Hz, 2H), 7.25 (d, J = 9.1 Hz, 2H), 6.20 (s, 1H), 5.93–5.88
(m, 1H), 5.48–5.41 (m, 1H), 3.65 (s, 3H), 2.43 (s, 3H), 2.40 (s,
3H), 2.31–2.19 (m, 1H), 2.13–1.94 (m, 2H), 1.90–1.70 (m, 4H),
1.70–1.52 (m, 5H), 1.36 (s, 3H), 1.27 (s, 3H), 1.25 (s, 3H),
1.17–0.96 (m, 2H), 0.78 (s, 3H). 13C NMR (75 MHz, CDCl3)
δ 179.1, 144.4, 142.9, 140.6, 139.6, 138.1, 134.8, 129.6 (2C),
129.3 (2C), 128.1 (2C), 126.9 (2C), 126.3, 124.8, 61.3, 52.0, 50.5,
46.6, 45.1, 38.4, 37.4, 34.5, 27.8, 26.7, 26.0, 25.3, 22.2, 21.7
(1C + 1C), 18.2, 17.1, 14.1. IR (ATR, neat): ν = 3219, 2990, 2929,
2860, 1721, 1597, 1300, 1244, 1148, 1103, 1088, 1017, 975,
908, 812, 727 cm−1. HRMS ESI (+): m/z [M + Na]+ calcd for
C35H46N2NaO5S2
+: 661.2740; found: 661.2721.
15-[N-(R)-(p-Toluenesulfonyl)-p-toluene-sulfonimidoyl]methyl-
abietadien-18-oate (17b)
17b was prepared following general procedure 2 starting from
15 (63.3 mg, 0.200 mmol) and the (R,R) pair of reagents. After
purification by flash chromatography (DCM/EtOAc 95 : 5), com-
pound 17b was obtained (63 mg, 48%) as a yellow amorphous
solid.
[α]20D = −70.0 (c = 1.00 in CHCl3).
1H NMR (300 MHz, CDCl3)
δ 7.82 (d, J = 8.3 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.25 (d, J =
8.2 Hz, 2H), 7.21 (d, J = 8.3 Hz, 2H), 6.29 (s, 1H), 5.94–5.88 (m,
1H), 5.44–5.36 (m, 1H), 3.62 (s, 3H), 2.40 (s, 3H), 2.38 (s, 3H),
2.09–1.96 (m, 2H), 1.95–1.85 (m, 2H), 1.81–1.66 (m, 4H),
1.65–1.44 (m, 4H), 1.44 (s, 3H), 1.32 (s, 3H), 1.23 (s, 3H),
1.13–0.98 (m, 1H), 0.64 (s, 3H), 0.24–0.08 (m, 1H). 13C NMR
(75 MHz, CDCl3) δ 179.0, 144.2, 142.9, 140.6, 137.8, 137.6,
134.6, 129.6 (2C), 129.3 (2C), 128.2 (2C), 127.3, 126.9 (2C),
124.7, 60.9, 52.0, 50.2, 46.6, 44.9, 38.3, 37.2, 34.4, 28.6, 27.1,
25.9, 25.7, 21.7 (1C + 1C), 21.4, 18.1, 17.1, 14.2. IR (ATR, neat):
ν = 3219, 2948, 2928, 2875, 2836, 1720, 1598, 1433, 1380, 1300,
1250, 1147, 1107, 1087, 1067, 1016, 970, 906, 811, 726 cm−1.





18a was prepared following general procedure 2 starting from
16 (66.1 mg, 0.200 mmol) and the (S,S) pair of reagents. After
purification by flash chromatography (DCM/EtOAc 95 : 5), com-
pound 18a was obtained (15 mg, 12%) as a yellow amorphous
solid.
[α]20D = +8.0 (c = 0.34 in CHCl3).
1H NMR (500 MHz, CDCl3)
δ 7.82 (d, J = 8.6 Hz, 2H), 7.76 (d, J = 8.4 Hz, 2H), 7.26 (d, J =
7.7 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 6.20 (s, 1H), 5.95–5.91 (m,
1H), 5.50–5.46 (m, 1H), 3.81 (d, J = 10.9 Hz, 1H), 3.68 (d, J =
11.0 Hz, 1H), 2.42 (s, 3H), 2.40 (s, 3H), 2.28–2.21 (m, 1H), 2.06
(s, 3H), 2.09–1.95 (m, 2H), 1.87–1.79 (m, 1H), 1.79–1.70 (m,
2H), 1.69–1.62 (m, 1H), 1.62–1.52 (m, 2H), 1.49 (dd, J = 11.7,
5.3 Hz, 1H), 1.46–1.32 (m, 2H), 1.37 (s, 3H), 1.24 (s, 3H),
1.15–1.05 (m, 1H), 1.01–0.92 (m, 1H), 0.94 (s, 3H), 0.79 (s, 3H).
13C NMR (75 MHz, CDCl3) δ 171.4, 144.4, 142.9, 140.6, 139.9,
138.2, 134.7, 129.6 (2C), 129.3 (2C), 128.0 (2C), 126.9 (2C),
126.2, 125.0, 72.8, 61.5, 50.3, 44.3, 38.8, 36.4, 36.3, 34.7, 27.5,
26.6, 25.3, 24.3, 22.5, 21.8, 21.7, 21.2, 18.1, 17.9, 14.2. IR (ATR,
neat): ν = 3231, 2924, 2849, 1733, 1598, 1451, 1379, 1299, 1238,
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1150, 1105, 1069, 1034, 976, 812, 749, 702 cm−1. HRMS ESI (+):





18b was prepared following general procedure 2 starting from
16 (66.1 mg, 0.200 mmol) and the (R,R) pair of reagents. After
purification by flash chromatography (DCM/EtOAc 95 : 5), com-
pound 18b was obtained (47 mg, 36%) as a yellow amorphous
solid.
[α]20D = −22.5 (c = 1.00 in CHCl3).
1H NMR (300 MHz, CDCl3)
δ 7.82 (d, J = 8.0 Hz, 2H), 7.71 (d, J = 8.1 Hz, 2H), 7.26 (d, J =
8.3 Hz, 2H), 7.22 (d, J = 8.3 Hz, 2H), 6.29 (s, 1H), 5.96–5.88 (m,
1H), 5.49–5.40 (m, 1H), 3.79 (d, J = 10.8 Hz, 1H), 3.64 (d, J =
10.8 Hz, 1H), 2.41 (s, 3H), 2.38 (s, 3H), 2.04 (s, 3H), 2.06–1.96
(m, 2H), 1.96–1.85 (m, 2H), 1.78–1.61 (m, 2H), 1.60–1.35 (m,
6H), 1.44 (s, 3H), 1.33 (s, 3H), 0.92 (s, 3H), 1.00–0.79 (m, 1H),
0.64 (s, 3H), 0.22–0.05 (m, 1H). 13C NMR (75 MHz, CDCl3)
δ 171.4, 144.2, 143.0, 140.6, 138.0, 137.7, 134.5, 129.6 (2C),
129.3 (2C), 128.2 (2C), 127.2, 126.9 (2C), 125.0, 72.7, 61.0,
50.0, 44.1, 38.8, 36.4, 36.2, 34.6, 28.5, 27.1, 25.7, 24.2, 21.7
(1C + 1C), 21.6, 21.2, 18.1, 17.9, 14.3. IR (ATR, neat): ν = 3237,
2927, 1733, 1597, 1447, 1432, 1380, 1299, 1240, 1149, 1089,
1067, 1033, 976, 908, 812, 729, 697 cm−1. HRMS ESI (+):





21 was prepared following general procedure 1 starting from
20 (106 mg, 0.300 mmol), TcesNH2 (68.5 mg, 0.300 mmol),
Rh2(esp)2 (11.4 mg, 15.0 µmol) and PhI(OPiv)2 (244 mg,
0.600 mmol). The oxidant was added over 1.5 h. After puri-
fication by flash chromatography (petroleum ether/EtOAc
85 : 15), the desired compound was obtained as a white amor-
phous solid (109 mg, 83%).
[α]20D = +84.8 (c = 1.00 in CHCl3).
1H NMR (500 MHz, CDCl3)
δ 7.59 (br s, 1H), 6.86 (t, J = 55.5 Hz, 1H), 6.81 (br s, 1H),
4.96–4.91 (m, 1H), 4.85–4.80 (m, 1H), 4.74 (d, J = 10.9 Hz, 1H),
4.72 (d, J = 10.9 Hz, 1H), 3.85 (s, 3H), 3.66 (s, 3H), 2.66–2.60
(m, 1H), 2.37–2.31 (m, 1H), 2.27–2.21 (m, 1H), 2.20 (ddd, J =
14.9, 13.1, 4.0 Hz, 1H), 1.99 (qt, J = 14.0, 3.7 Hz, 1H), 1.70 (dd,
J = 13.0, 1.6 Hz, 1H), 1.72–1.64 (m, 1H), 1.38 (td, J = 13.3,
4.0 Hz, 1H), 1.32 (s, 3H), 1.14 (td, J = 13.6, 4.2 Hz, 1H), 0.99
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 177.5 (s), 157.6 (t, J =
5.5 Hz), 153.4 (d, J = 1.9 Hz), 128.5 (t, J = 5.6 Hz), 124.7 (s),
122.0 (t, J = 22.5 Hz), 111.3 (t, J = 236.0 Hz), 107.9 (s), 93.7 (s),
78.1 (s), 55.8 (s), 54.0 (s), 51.6 (s), 46.2 (s), 43.7 (s), 39.3 (s),
39.1 (s), 37.5 (s), 28.4 (s), 27.8 (s), 22.1 (s), 19.8 (s). 19F NMR
(471 MHz, CDCl3) δ −114.5 (d, J = 299.0 Hz), −116.0 (d, J =
299.0 Hz). IR (ATR, neat): ν = 3284, 3107, 2955, 2853, 1728,
1702, 1514, 1469, 1432, 1349, 1266, 1228, 1179, 1153, 1179,
1076, 1047, 1018, 965, 853, 843, 755, 144, 122, 634, 530 cm−1.






Sulfamate 22 (76.0 mg, 0.208 mmol), Rh2(CF3CONH)4 (3.8 mg,
6.0 µmol) and MgO (15.3 mg, 0.380 mmol) were charged in a
sealed tube under an argon atmosphere. Anhydrous benzene
(1.0 ml) was then added, followed by PhI(OAc)2 (83.7 mg,
0.260 mmol). The reaction mixture was stirred at 65 °C
for 16 h, filtered through a pad of Celite and washed with
EtOAc. After concentration under reduced pressure, the brown
residue was purified by flash chromatography (petroleum
ether/EtOAc 90 : 10) to afford 23 (54 mg, 71%) as a white amor-
phous solid.
[α]20D = +11.3 (c = 1.00 in CHCl3).
1H NMR (300 MHz, CDCl3)
δ 7.13 (d, J = 8.2 Hz, 1H), 7.03 (dd, J = 8.2, 1.9 Hz, 1H), 6.93
(d, J = 1.9 Hz, 1H), 4.45 (d, J = 12.4 Hz, 1H), 4.33 (d, J = 9.7 Hz,
1H), 4.22 (d, J = 12.6 Hz, 1H), 3.68 (dt, J = 9.6, 3.3 Hz, 1H),
3.03–2.93 (m, 2H), 2.84 (sept, J = 6.9 Hz, 1H), 2.32–2.15 (m,
2H), 2.13 (dd, J = 11.4, 3.2 Hz, 1H), 1.91–1.69 (m, 3H), 1.59 (td,
J = 15.3, 3.7 Hz, 1H), 1.27 (s, 3H), 1.23 (d, J = 7.0 Hz, 6H), 0.95
(s, 3H). 13C NMR (75 MHz, CDCl3) δ 146.6, 145.8, 134.3, 127.1,
124.4, 123.9, 77.6, 59.6, 37.1, 36.6, 34.5, 33.6, 31.5, 29.5, 25.6,
24.1 (1C + 1C), 23.1, 18.2, 16.6. IR (ATR, neat): ν = 3288, 2957,
2869, 1498, 1563, 1413, 1356, 1173, 1054, 993, 972, 928, 884,
821, 781, 710, 664 cm−1. HRMS ESI (+): m/z [M + H]+ calcd for
C20H30NO3S
+: 364.1941; found: 364.1950.
(4aS,4bR,10bS,12aR)-8-Isopropyl-4a,10b-dimethyl-
1,4,4a,4b,10b,11,12,12a-octahydrophenanthro[2,1-d][1,2,3]-
oxathiazine 2,2-dioxide (25) and aziridine (34)
Sulfamate 24 (218 mg, 0.600 mmol), Rh2(esp)2 (13.6 mg,
18.0 µmmol) and MgO (45.9 mg, 1.14 mmol) were charged in
a sealed tube under an argon atmosphere. Then anhydrous
DCM (3.0 ml) was added and the mixture was cooled to
0 °C with an ice bath before adding PhI(OAc)2 (251 mg,
0.780 mmol). The reaction mixture was stirred at r.t. for 16 h,
filtered through a pad of Celite and washed with EtOAc. After
concentration under reduced pressure, the brown residue was
purified by flash chromatography (petroleum ether/EtOAc
90 : 10 to 80 : 20) to afford 25 (92 mg, 42%) as a white amor-
phous solid and 34 (74 mg, 17%) as a yellow amorphous solid.
Compound 25. [α]20D = −72.0 (c = 1.00 in CHCl3).
1H NMR
(300 MHz, CDCl3) δ 7.12 (dd, J = 8.0, 1.6 Hz, 1H), 7.06 (d, J =
8.0 Hz, 1H), 6.97 (d, J = 1.6 Hz, 1H), 6.67 (dd, J = 9.6, 3.1 Hz,
1H), 5.78 (dd, J = 9.6, 2.8 Hz, 1H), 4.42 (d, J = 9.4 Hz, 1H), 4.35
(d, J = 12.4 Hz, 1H), 4.27 (d, J = 12.4 Hz, 1H), 3.71 (dt, J = 9.5,
3.2 Hz, 1H), 2.96–2.79 (m, 2H), 2.24 (tt, J = 16.6, 4.3 Hz, 1H),
2.16–2.06 (m, 1H), 1.84 (td, J = 13.0, 3.8 Hz, 1H), 1.90–1.75 (m,
1H), 1.25 (d, J = 7.0 Hz, 6H), 1.11 (s, 3H), 1.05 (s, 3H). 13C NMR
(75 MHz, CDCl3) δ 147.1, 144.2, 132.3, 130.5, 126.5, 125.8,
125.1, 121.7, 77.1, 59.1, 38.0, 37.4, 33.8, 33.5, 28.8, 24.1
(1C + 1C), 23.0, 21.0, 17.6. IR (ATR, neat): ν = 3306, 2962, 2942,
2925, 2868, 1469, 1442, 1420, 1362, 1188, 1050, 1025, 994, 969,
927, 891, 823, 787, 775 cm−1. HRMS ESI (+): m/z [M + H]+ calcd
for C20H28NO3s
+: 362.1784; found: 362.1783.
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Compound 34. 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J =
2.0 Hz, 1H), 7.23 (dd, J = 8.1, 2.0 Hz, 1H), 7.09 (d, J = 8.1 Hz,
1H), 7.08 (d, J = 8.0 Hz, 1H), 7.05 (dd, J = 8.0, 1.7 Hz, 1H), 6.90
(d, J = 1.7 Hz, 1H), 6.55 (dd, J = 9.6, 3.0 Hz, 1H), 5.91 (dd, J =
9.6, 2.6 Hz, 1H), 4.55 (d, J = 12.5 Hz, 1H), 4.38 (d, J = 12.5 Hz,
1H), 4.22–4.16 (m, 2H), 4.11 (d, J = 9.5 Hz, 1H), 3.85 (d, J =
7.4 Hz, 1H), 3.79–3.73 (m, 1H), 3.18 (dd, J = 7.6, 6.1 Hz, 1H),
2.93 (sept, J = 6.9 Hz, 1H), 2.85 (sept, J = 7.0 Hz, 1H), 2.40 (t,
J = 2.9 Hz, 1H), 2.28–2.14 (m, 2H), 2.21 (d, J = 6.4 Hz, 1H),
2.12–2.05 (m, 1H), 1.85–1.73 (m, 4H), 1.70–1.54 (m, 3H), 1.29
(d, J = 6.5 Hz, 3H), 1.28 (s, 3H), 1.28 (d, J = 6.4 Hz, 3H), 1.23 (d,
J = 7.0 Hz, 3H), 1.23 (d, J = 7.0 Hz, 3H), 1.18 (s, 3H), 1.10 (s,
3H), 1.08 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 148.0, 147.1,
146.4, 145.3, 132.6, 129.1, 129.0, 127.9, 127.8 (1C + 1C), 125.9,
124.8, 122.8, 121.8, 81.2, 77.8, 58.9, 45.5, 40.3, 40.2, 39.6, 37.6,
37.0, 36.8, 35.5, 34.7, 34.1, 33.8, 33.7, 29.5, 26.0, 24.2, 24.1
(1C + 1C), 23.9, 22.7, 20.9, 18.2, 17.8, 17.2. IR (ATR neat): ν =
2559, 2932, 2869, 2097, 1682, 1462, 1444, 1359, 1177, 994, 974,
909, 858, 828, 773, 718 cm−1. HRMS ESI (−): m/z [M + H]−
calcd for C40H53N2O6S2




Sulfamate 26 (70.7 mg, 0.200 mmol), Rh2(esp)2 (4.6 mg,
6.0 µmol) and MgO (15.3 mg, 0.380 mmol) were charged in a
sealed tube under an argon atmosphere. Anhydrous DCM
(1.0 ml) was then added, followed by PhI(OAc)2 (83.7 mg,
0.260 mmol). The reaction mixture was stirred at r.t. for 16 h,
filtered through a pad of Celite and washed with EtOAc. After
concentration under reduced pressure, the brown residue was
purified by flash chromatography (petroleum ether/EtOAc
85 : 15) to afford compound 27 (29 mg, 41%) as a white solid.
M.p.: Decomposition at 265 °C. [α]20D = +2.9 (c = 0.75 in
CHCl3).
1H NMR (500 MHz, CDCl3) δ 6.97 (d, J = 8.4 Hz, 1H),
6.78 (d, J = 2.6 Hz, 1H), 6.70 (dd, J = 8.4, 2.6 Hz, 1H), 5.17 (d,
J = 11.7 Hz, 1H), 4.87 (d, J = 5.9 Hz, 1H), 4.10 (dd, J = 11.8, 2.2
Hz, 1H), 3.78 (s, 3H), 3.06–2.99 (m, 1H), 2.98–2.91 (m, 1H),
2.88–2.78 (m, 1H), 2.76 (qd, J = 13.9, 3.4 Hz, 1H), 2.42 (dt, J =
13.3, 3.6 Hz, 1H), 2.08–1.94 (m, 2H), 1.71–1.60 (m, 1H), 1.59
(d, J = 13.0 Hz, 1H), 1.51 (td, J = 13.7, 3.6 Hz, 1H), 1.42 (s, 3H),
1.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.1, 149.0, 130.1,
126.3, 111.7, 110.1, 75.2, 64.1, 55.5, 49.8, 37.5, 37.0, 36.1, 29.5,
25.5, 24.7, 24.3, 19.0. IR (ATR, neat): ν = 3349, 3318, 3254,
2985, 2951, 2916, 2162, 1607, 1575, 1503, 1434, 1357, 1251,
1185, 1039, 973, 928, 833, 760, 552, 540, 532 cm−1. HRMS ESI






Compound 28 (147 mg, 0.400 mmol), Rh2(CF3CONH)4
(7.6 mg, 12 µmol) and MgO (30.6 mg, 0.760 mmol) were
charged in a round bottom flask under an argon atmosphere.
Then anhydrous DCM (2.4 ml) was added and the mixture was
cooled to 0 °C with an ice bath before adding PhI(OAc)2
(168 mg, 0.520 mmol). The mixture was stirred at r.t. for 19 h
(until the disappearance of the starting material by TLC),
filtered through a pad of Celite and washed with EtOAc. After
concentration under reduced pressure, the brown residue was
purified by flash chromatography (petroleum ether/EtOAc
85 : 15) to afford 29 (42 mg, 29%) as a slightly yellow solid.
M.p.: 123–125 °C. [α]20D = −40.0 (c = 1.00 in CHCl3).
1H NMR
(300 MHz, CDCl3) δ 5.78 (s, 1H), 5.25 (t, J = 2.7 Hz, 1H, H-7),
4.39 (d, J = 10.3 Hz, 1H), 4.12 (d, J = 12.1 Hz, 1H), 4.14–4.02
(m, 1H, H-6), 3.61 (d, J = 12.2 Hz, 1H), 2.26 (sept, J = 6.8 Hz,
1H), 2.18–1.97 (m, 2H), 1.94–1.74 (m, 4H), 1.74–1.55 (m, 1H),
1.37 (d, J = 10.0 Hz, 1H), 1.37–1.28 (m, 1H), 1.25 (s, 3H),
1.32–1.18 (m, 1H), 1.17–1.06 (m, 2H), 1.03 (d, J = 6.7 Hz, 3H),
1.02 (d, J = 6.8 Hz, 3H), 0.85 (s, 3H). 13C NMR (75 MHz, CDCl3)
δ 149.8, 138.9, 121.5, 118.7, 82.3, 60.3, 50.8 (C-6), 49.4, 38.6,
38.3, 37.8, 35.4 (C-3), 35.2, 27.2, 22.0, 21.3, 20.8, 18.2, 17.7,
14.0. IR (ATR, neat): ν = 3828, 2921, 2851, 1712, 1655, 1446,
1424, 1338, 1178, 1036, 971, 951, 931, 890, 850, 779 cm−1.






Compound 30 (80.0 mg, 0.195 mmol), Rh2(CF3CONH)4
(3.8 mg, 5.9 µmol), and MgO (14.9 mg, 0.371 mmol) were
charged in a round bottom flask under an argon atmosphere.
Then anhydrous DCM (2.4 ml) was added and the mixture was
cooled to 0 °C with an ice bath before adding PhI(OAc)2
(81.7 mg, 0.254 mmol). The mixture was stirred at r.t. until the
disappearance of the starting material by TLC, filtered through
a pad of Celite and washed with EtOAc. After concentration
under reduced pressure, the brown residue was purified by
flash chromatography (petroleum ether/EtOAc 85 : 15) to
afford 31 (62 mg, 76%) as a slightly pink solid.
M.p.: Decomposition at 230 °C. [α]20D = +49.5 (c = 0.92 in
CHCl3).
1H NMR (300 MHz, CDCl3) δ 6.86 (s, 1H), 6.85 (s, 1H),
4.55 (s, 1H), 3.67 (s, 3H), 2.92–2.81 (m, 2H), 2.26–2.16 (m, 1H),
2.17 (dd, J = 12.3, 2.1 Hz, 1H), 1.92–1.62 (m, 5H), 1.69 (s, 3H),
1.68 (s, 3H), 1.47 (td, J = 12.3, 4.7 Hz, 1H), 1.49–1.38 (m, 1H),
1.27 (s, 3H), 1.20 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 179.0,
151.4, 147.7, 132.8, 126.7, 125.1, 114.8, 60.1, 52.2, 47.6, 44.5,
37.9, 37.4, 36.7, 31.0, 30.9, 29.4, 25.0, 21.5, 18.5, 16.7. IR (ATR,
neat): ν = 3219, 2999, 2940, 2926, 2873, 2846, 1694, 1496, 1437,
1401, 1384, 1358, 1254, 1155, 1110, 1020, 991, 905, 853, 845,






In a sealed tube equipped with a magnetic bar under an argon
atmosphere, carbamate 32 was added (224 mg, 0.600 mmol)
followed by MgO (53.2 mg, 1.32 mmol), PhI(OAc)2 (251 mg,
0.780 mmol), 4 Å MS (200 wt%), and Rh2(octanoate)4 (23.4 mg,
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30.0 µmol) and anhydrous toluene (4.0 ml). The reaction
vessel was sealed and was stirred at 100 °C until the dis-
appearance of the starting material (12 h). The reaction
mixture was then filtered through a pad of Celite and the
residue obtained after the concentration under reduced
pressure was dissolved in DCM and 5 ml of a saturated solu-
tion of thiourea were added. The orange biphasic mixture was
stirred vigorously for 30 min. The content was transferred to a
separatory funnel, and the organic phase was collected. The
aqueous layer was extracted with DCM (2 × 15 ml). The com-
bined organic extracts were washed with brine (2 × 15 ml),
dried over Na2SO4, filtered, and the filtrate was concentrated
under reduced pressure. Purification of the isolated material
by flash chromatography (petroleum ether/EtOAc 8 : 2)
afforded the desired product (95 mg, 43% yield) as a pale
yellow solid.
M.p.: Decomposition at 241 °C. [α]20D = +99.4 (c = 1.00 in
CHCl3).
1H NMR (500 MHz, CDCl3) δ 9.64 (s, 1H), 6.68 (s, 1H),
3.69 (s, 3H), 3.18 (sept, J = 6.9 Hz, 1H), 2.95 (ddd, J = 16.4,
12.0, 6.3 Hz, 1H), 2.86 (ddd, J = 16.8, 6.2, 1.4 Hz, 1H),
2.43–2.36 (m, 1H), 2.27 (dd, J = 12.2, 1.8 Hz, 1H), 1.93–1.84 (m,
1H), 1.81 (td, J = 12.6, 3.3 Hz, 1H), 1.81–1.70 (m, 2H),
1.70–1.64 (m, 1H), 1.58 (td, J = 12.6, 3.5 Hz, 1H), 1.43–1.37
(m, 1H), 1.36 (s, 3H), 1.30 (s, 3H), 1.29 (d, J = 6.9 Hz, 3H), 1.28
(d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 179.0, 156.3,
140.3, 131.9, 130.2, 129.1, 125.7, 121.2, 52.2, 48.0, 46.3, 37.8,
36.9, 36.3, 31.5, 28.3, 22.6, 22.4, 22.0, 21.8, 18.5, 16.8. IR (ATR,
neat): ν = 3248, 3228, 2964, 2945, 2929, 2875, 1745, 1731, 1716,
1637, 1590, 1430, 1414, 1386, 1332, 1247, 1206, 1175, 1134,
1113, 1084, 1053, 936, 882, 813, 792, 762, 727 cm−1. HRMS ESI
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